JACC:Fontan修复术后房室瓣功能不全的临床研究

2019-02-24 不详 MedSci原创

在接受Fontan 修复术的患者中,房室瓣的功能不全(中重度反流或瓣膜手术)是不良临床预后的危险因素。本研究的目的旨在评估接受Fontan 修复术患者的房室瓣功能不全发病率和预后结局。本研究共纳入了1468名接受Fontan 修复术的患者,其中1199名完成了全部的随访,其中686名患者有两个房室瓣膜,286名有单一二尖瓣,130名有共同房室瓣,97名有单一三尖瓣。110名患者接受了132次房室瓣

在接受Fontan 修复术的患者中,房室瓣的功能不全(中重度反流或瓣膜手术)是不良临床预后的危险因素。本研究的目的旨在评估接受Fontan 修复术患者的房室瓣功能不全发病率和预后结局。

本研究共纳入了1468名接受Fontan 修复术的患者,其中1199名完成了全部的随访,其中686名患者有两个房室瓣膜,286名有单一二尖瓣,130名有共同房室瓣,97名有单一三尖瓣。110名患者接受了132次房室瓣修复术,13名患者接受了15次置换术。拥有共同房室瓣、单一二尖瓣、单一三尖瓣和2个房室瓣患者25岁时的房室瓣功能不全发病率分别为 56% (95% [CI]: 46%-67%), 46% (95% CI: 31%-61%), 8% (95% CI: 4%-12%)和26% (95% CI: 21%-30%)。在无瓣膜功能不全的患者中,Fontan 修复术后10年和20年的治愈率分别为91% (95% CI: 89%-93%)和77% (95% CI: 73%-81%),而伴有瓣膜功能不全的患者分别是77% (95% CI: 69%-85%)和54% (95% CI: 42%-68%)。

研究结果显示,在接受Fontan 修复术的患者中,房室瓣功能不全的发生率很高,伴有房室瓣功能不全的患者的Fontan 循环失败率是不伴有患者的两倍。

原始出处:

本文系梅斯医学(MedSci)原创编译整理,转载需授权

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1928120, encodeId=3b041928120d5, content=<a href='/topic/show?id=4a722e395ce' target=_blank style='color:#2F92EE;'>#修复术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27395, encryptionId=4a722e395ce, topicName=修复术)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Mon Aug 12 23:29:00 CST 2019, time=2019-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1699970, encodeId=df6e16999e0d3, content=<a href='/topic/show?id=e720e583c0' target=_blank style='color:#2F92EE;'>#Fontan#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7583, encryptionId=e720e583c0, topicName=Fontan)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=284729986400, createdName=changjitao2019, createdTime=Sat Dec 07 12:29:00 CST 2019, time=2019-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1854324, encodeId=3b641854324d9, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Mon Oct 07 09:29:00 CST 2019, time=2019-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=361668, encodeId=9e103616686f, content=该修复术还有其他用途, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57ab1959292, createdName=boc_111, createdTime=Thu Feb 28 13:23:17 CST 2019, time=2019-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1326140, encodeId=b6241326140ef, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Tue Feb 26 04:29:00 CST 2019, time=2019-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=361481, encodeId=aec63614811e, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57ab1959292, createdName=boc_111, createdTime=Mon Feb 25 12:29:00 CST 2019, time=2019-02-25, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1928120, encodeId=3b041928120d5, content=<a href='/topic/show?id=4a722e395ce' target=_blank style='color:#2F92EE;'>#修复术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27395, encryptionId=4a722e395ce, topicName=修复术)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Mon Aug 12 23:29:00 CST 2019, time=2019-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1699970, encodeId=df6e16999e0d3, content=<a href='/topic/show?id=e720e583c0' target=_blank style='color:#2F92EE;'>#Fontan#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7583, encryptionId=e720e583c0, topicName=Fontan)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=284729986400, createdName=changjitao2019, createdTime=Sat Dec 07 12:29:00 CST 2019, time=2019-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1854324, encodeId=3b641854324d9, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Mon Oct 07 09:29:00 CST 2019, time=2019-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=361668, encodeId=9e103616686f, content=该修复术还有其他用途, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57ab1959292, createdName=boc_111, createdTime=Thu Feb 28 13:23:17 CST 2019, time=2019-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1326140, encodeId=b6241326140ef, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Tue Feb 26 04:29:00 CST 2019, time=2019-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=361481, encodeId=aec63614811e, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57ab1959292, createdName=boc_111, createdTime=Mon Feb 25 12:29:00 CST 2019, time=2019-02-25, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1928120, encodeId=3b041928120d5, content=<a href='/topic/show?id=4a722e395ce' target=_blank style='color:#2F92EE;'>#修复术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27395, encryptionId=4a722e395ce, topicName=修复术)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Mon Aug 12 23:29:00 CST 2019, time=2019-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1699970, encodeId=df6e16999e0d3, content=<a href='/topic/show?id=e720e583c0' target=_blank style='color:#2F92EE;'>#Fontan#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7583, encryptionId=e720e583c0, topicName=Fontan)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=284729986400, createdName=changjitao2019, createdTime=Sat Dec 07 12:29:00 CST 2019, time=2019-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1854324, encodeId=3b641854324d9, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Mon Oct 07 09:29:00 CST 2019, time=2019-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=361668, encodeId=9e103616686f, content=该修复术还有其他用途, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57ab1959292, createdName=boc_111, createdTime=Thu Feb 28 13:23:17 CST 2019, time=2019-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1326140, encodeId=b6241326140ef, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Tue Feb 26 04:29:00 CST 2019, time=2019-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=361481, encodeId=aec63614811e, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57ab1959292, createdName=boc_111, createdTime=Mon Feb 25 12:29:00 CST 2019, time=2019-02-25, status=1, ipAttribution=)]
    2019-10-07 hbwxf
  4. [GetPortalCommentsPageByObjectIdResponse(id=1928120, encodeId=3b041928120d5, content=<a href='/topic/show?id=4a722e395ce' target=_blank style='color:#2F92EE;'>#修复术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27395, encryptionId=4a722e395ce, topicName=修复术)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Mon Aug 12 23:29:00 CST 2019, time=2019-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1699970, encodeId=df6e16999e0d3, content=<a href='/topic/show?id=e720e583c0' target=_blank style='color:#2F92EE;'>#Fontan#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7583, encryptionId=e720e583c0, topicName=Fontan)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=284729986400, createdName=changjitao2019, createdTime=Sat Dec 07 12:29:00 CST 2019, time=2019-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1854324, encodeId=3b641854324d9, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Mon Oct 07 09:29:00 CST 2019, time=2019-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=361668, encodeId=9e103616686f, content=该修复术还有其他用途, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57ab1959292, createdName=boc_111, createdTime=Thu Feb 28 13:23:17 CST 2019, time=2019-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1326140, encodeId=b6241326140ef, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Tue Feb 26 04:29:00 CST 2019, time=2019-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=361481, encodeId=aec63614811e, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57ab1959292, createdName=boc_111, createdTime=Mon Feb 25 12:29:00 CST 2019, time=2019-02-25, status=1, ipAttribution=)]
    2019-02-28 boc_111

    该修复术还有其他用途

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1928120, encodeId=3b041928120d5, content=<a href='/topic/show?id=4a722e395ce' target=_blank style='color:#2F92EE;'>#修复术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27395, encryptionId=4a722e395ce, topicName=修复术)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Mon Aug 12 23:29:00 CST 2019, time=2019-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1699970, encodeId=df6e16999e0d3, content=<a href='/topic/show?id=e720e583c0' target=_blank style='color:#2F92EE;'>#Fontan#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7583, encryptionId=e720e583c0, topicName=Fontan)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=284729986400, createdName=changjitao2019, createdTime=Sat Dec 07 12:29:00 CST 2019, time=2019-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1854324, encodeId=3b641854324d9, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Mon Oct 07 09:29:00 CST 2019, time=2019-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=361668, encodeId=9e103616686f, content=该修复术还有其他用途, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57ab1959292, createdName=boc_111, createdTime=Thu Feb 28 13:23:17 CST 2019, time=2019-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1326140, encodeId=b6241326140ef, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Tue Feb 26 04:29:00 CST 2019, time=2019-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=361481, encodeId=aec63614811e, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57ab1959292, createdName=boc_111, createdTime=Mon Feb 25 12:29:00 CST 2019, time=2019-02-25, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1928120, encodeId=3b041928120d5, content=<a href='/topic/show?id=4a722e395ce' target=_blank style='color:#2F92EE;'>#修复术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27395, encryptionId=4a722e395ce, topicName=修复术)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Mon Aug 12 23:29:00 CST 2019, time=2019-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1699970, encodeId=df6e16999e0d3, content=<a href='/topic/show?id=e720e583c0' target=_blank style='color:#2F92EE;'>#Fontan#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7583, encryptionId=e720e583c0, topicName=Fontan)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=284729986400, createdName=changjitao2019, createdTime=Sat Dec 07 12:29:00 CST 2019, time=2019-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1854324, encodeId=3b641854324d9, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Mon Oct 07 09:29:00 CST 2019, time=2019-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=361668, encodeId=9e103616686f, content=该修复术还有其他用途, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57ab1959292, createdName=boc_111, createdTime=Thu Feb 28 13:23:17 CST 2019, time=2019-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1326140, encodeId=b6241326140ef, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Tue Feb 26 04:29:00 CST 2019, time=2019-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=361481, encodeId=aec63614811e, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57ab1959292, createdName=boc_111, createdTime=Mon Feb 25 12:29:00 CST 2019, time=2019-02-25, status=1, ipAttribution=)]
    2019-02-25 boc_111

    谢谢分享

    0

相关资讯

JACC:PCI术后输注比伐卢定可改善预后

急性冠脉综合征(ACS)患者经皮冠脉介入(PCI)术后比伐卢定长期输注的价值和意义尚不清楚。本研究的目的旨在评估ACS患者PCI术后全或低比伐卢定输注的安全性和有效性。本研究纳入了MATRIX 临床研究中的患者,主要终点事件是紧急靶血管血运重建、明确的支架血栓形成或不良临床事件的复合事件。最终,共纳入分析了3610名患者,其中1799名患者接受有PCI术后比伐卢定输注,1811名没有。有612名患

JACC Heart Failure:钠-葡萄糖协同转运蛋白2抑制剂用于心血管疾病的全新实用指导

2019年2月,发表于《JACC》上的一项研究,为心血管医师处方钠-葡萄糖协同转运蛋白2(SGLT2)抑制剂提供实用性指导。

Am J Crit Care:睡眠呼吸暂停患者若白天嗜睡,心血管病风险明显升高

美国呼吸与危重病医学杂志在线公布的最新研究表明,患有阻塞性睡眠呼吸暂停(OSA)的成年人在白天出现过度嗜睡,其患心血管疾病的风险比那些没有过度白天嗜睡的人大得多。

盘点:JACC二月第三期研究一览

1.冠心病伴糖尿病患者冠脉搭桥远期死亡率低于介入治疗DOI: 10.1016/j.jacc.2018.11.001http://www.onlinejacc.org/content/73/6 FREEDOM临床研究结果显示对于伴有多支冠脉病变(MVD)的糖尿病患者, 随访3.8年后,冠脉搭桥手术(CABG)在减少主要心脑血管不良事件方面要优于药物洗脱支架的介入治疗(PCI-DES)。

Circ Res:坚果,能降低糖尿病患者的心血管疾病风险!

吃坚果能为我们的健康带来诸多益处已是人尽皆知的事情,包括改善肠道健康与代谢,降低心血管疾病风险,有助于提高记忆力等。有益健康。

美发布心脏超声培训声明,所有心血管医生都应了解超声

美国心脏病学会、美国心脏协会和美国超声心动图学会的一份新的高级培训声明首次规定了执行 “三级”培训的培训要求。